Skip to content

Advertisement

BMC Urology

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Impact of a protein-based assay that predicts prostate cancer aggressiveness on urologists’ recommendations for active treatment or active surveillance: a randomized clinical utility trial

BMC UrologyBMC series – open, inclusive and trusted201717:51

https://doi.org/10.1186/s12894-017-0243-1

Received: 13 July 2016

Accepted: 27 June 2017

Published: 3 July 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
13 Jul 2016 Submitted Original manuscript
20 Mar 2017 Reviewed Reviewer Report - Christopher Filson
7 Apr 2017 Reviewed Reviewer Report - Jeffrey Tosoian
12 May 2017 Author responded Author comments - John Peabody
Resubmission - Version 2
12 May 2017 Submitted Manuscript version 2
16 May 2017 Reviewed Reviewer Report - Christopher Filson
29 May 2017 Reviewed Reviewer Report - Jeffrey Tosoian
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
27 Jun 2017 Editorially accepted
3 Jul 2017 Article published 10.1186/s12894-017-0243-1

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
QURE Healthcare
(2)
University of California
(3)
Metamark Genetics

Advertisement